Atorvastatin, tablets, 20 mg each;Atorvastatin, tablets, 40 mg each;Bisoprolol tablets of 5 mg;Propofol, emulsion, 10 mg/ml, 20 ml each;Propofol, emulsion, 20 mg/ml, 50 ml each;Atracurium, solution for injection, 10 mg/ml, 5 ml each;Torasemide, solution for injection, 5 mg/ml, 4 ml each;Torasemide, tablets, 10 mg each;Human insulin (Combination: 30% Short-acting; 70% Medium-acting), suspension for injection, 100 U/ml, bottle, 5 ml
By: Nadia Yurets๐ UkraineClosed
Key Information
| Reference | GB-UA-2026-11-16-015243-a |
|---|
| Deadline | Nov 19, 2026 12:00 AM |
|---|
| Estimated Value | UAH 19,158,900.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 88014, Ukraine, Zakarpattia Oblast, Uzhgorod city, Oleg Kutsyn St. (Timiryazev St.), building 15 A |
|---|
| Published | Nov 16, 2026 |
|---|
Description
Atorvastatin, tablets, 20 mg each;Atorvastatin, tablets, 40 mg each;Bisoprolol tablets of 5 mg;Propofol, emulsion, 10 mg/ml, 20 ml each;Propofol, emulsion, 20 mg/ml, 50 ml each;Atracurium, solution fo...
Full details are available after unlocking this tender.